Microprinting of liver micro-organ for drug metabolism study.

In their normal in vivo matrix milieu, tissues assume complex well-organized 3D architectures. Therefore, a primary aim in the tissue engineering design process is to fabricate an optimal analog of the in vivo scenario, in which the precise configuration and composition of cells and bioactive matrix components can establish the well-defined biomimetic microenvironments that promote cell-cell and cell-matrix interactions. With the advent and refinements in microfabricated systems which can present physical and chemical cues to cells in a controllable and reproducible fashion unrealizable with conventional tissue culture, high-fidelity, high-throughput in vitro models are achieved. The convergence of solid freeform fabrication (SFF) technologies, namely microprinting, along with microfabrication techniques, a 3D microprinted micro-organ, can serve as an in vitro platform for cell culture, drug screening, or to elicit further biological insights. This chapter firstly details the principles, methods, and applications that undergird the fabrication process development and adaptation of microfluidic devices for the creation of a drug screening model. This model involves the combinatorial setup of an automated syringe-based, layered direct cell writing microprinting process with soft lithographic micropatterning techniques to fabricate a microscale in vitro device housing a chamber of microprinted 3D micro-organ that biomimics the cell's natural microenvironment for enhanced performance and functionality. In order to assess the structural formability and biological feasibility of such a micro-organ, 3D cell-encapsulated hydrogel-based tissue constructs are microprinted reproducibly in defined design patterns and biologically characterized for both viability and cell-specific function. Another key facet of the in vivo microenvironment that is recapitulated with the in vitro system is the necessary dynamic perfusion of the 3D microscale liver analog with cells probed for their collective drug metabolic function and suitability as a drug metabolism model.

[1]  Wei Sun,et al.  Multi‐nozzle deposition for construction of 3D biopolymer tissue scaffolds , 2005 .

[2]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[3]  M J Bissell,et al.  Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Abbott.  Cell culture: Biology's new dimension , 2003, Nature.

[5]  Wei Sun,et al.  Biopolymer deposition for freeform fabrication of hydrogel tissue constructs , 2007 .

[6]  J M Cooper,et al.  Single-cell measurements of purine release using a micromachined electroanalytical sensor. , 1998, Analytical chemistry.

[7]  R Langer,et al.  Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. , 1997, Journal of biomedical materials research.

[8]  M L Shuler,et al.  A self-regulating cell culture analog device to mimic animal and human toxicological responses. , 1996, Biotechnology and bioengineering.

[9]  Wei Sun,et al.  Effects of dispensing pressure and nozzle diameter on cell survival from solid freeform fabrication-based direct cell writing. , 2008, Tissue engineering. Part A.

[10]  R. Narayan,et al.  Three-dimensional direct writing of B35 neuronal cells. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[11]  M L Shuler,et al.  Combining Cell Culture Analogue Reactor Designs and PBPK Models to Probe Mechanisms of Naphthalene Toxicity , 2000, Biotechnology progress.

[12]  A. Rich,et al.  Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[14]  Carlos E Semino,et al.  Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. , 2003, Differentiation; research in biological diversity.

[15]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[16]  Jae Nam,et al.  Direct cell writing of 3D microorgan for in vitro pharmacokinetic model. , 2008, Tissue engineering. Part C, Methods.

[17]  J. Castracane,et al.  Amperometric detection of quantal catecholamine secretion from individual cells on micromachined silicon chips. , 2003, Analytical chemistry.

[18]  Aaron Sin,et al.  Development of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity , 2008, Biotechnology progress.

[19]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[20]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[21]  K. Jensen,et al.  Cells on chips , 2006, Nature.

[22]  Jeffrey T Borenstein,et al.  Microfabrication of three-dimensional engineered scaffolds. , 2007, Tissue engineering.

[23]  M J Lysaght,et al.  The growth of tissue engineering. , 2001, Tissue engineering.

[24]  L. Griffith,et al.  Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor. , 2002, Tissue engineering.

[25]  Alan Rick Horwitz,et al.  Visualizing muscle cell migration in situ , 2000, Current Biology.

[26]  D. Beebe,et al.  Cell culture models in microfluidic systems. , 2008, Annual review of analytical chemistry.

[27]  L. Griffith,et al.  A microfabricated array bioreactor for perfused 3D liver culture. , 2002, Biotechnology and bioengineering.